Late Phase A A A

UNDERSTANDING THE REAL WORLD REQUIRES COMMITMENT

Of course a new product cannot be judged a success simply from its promising clinical trial results. It needs to achieve its commercial objectives to justify initial investment.
Our Global Late Phase Group of specialist project managers and experienced clinical development professionals are focused on providing specific services designed to support products from their launch through to market planning.
Our expert teams provide Phase IIIb and IV, Non-Interventional, Observational, Epidemiology, Investigator-Initiated trials and Registry services, in both national and international markets.

They provide and interpret data that addresses the long-term safety commitments required by the relevant authorities and can plan and deliver with the same passion and commitment shown during the earlier clinical phases.